A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib

NCT01645085 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MCC-based 13% drug loaded tablets
DRUG: Mannitol-based 38% drug-loaded tablet
DRUG: MCC-based 13% drug loaded tablets
DRUG: Mannitol-based 38% drug-loaded tablet

Sponsor

AstraZeneca